Data on appropriate treatment for periampullary cancers are lacking. For the most part, clinicians tend to treat these cancers in the same way that they treat pancreatic cancers, with similar surgical ...

Today, the FDA approved durvalumab (Imfinzi; AstraZeneca) in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as a neoadjuvant and adjuvant treatment, followed ...

Researchers sought to determine whether survival outcomes for patients with early breast cancer was better with NACT or ACT when pCR was not achieved.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Meyerhardt is ...

Please provide your email address to receive an email when new articles are posted on . Patients who started adjuvant chemotherapy more than 6 weeks after colorectal cancer surgery achieved poorer DFS ...

A new study, published in the Journal of Thoracic Oncology, has found that chemotherapy administered in patients with stage I disease, following a complete resection, can have a significant impact on ...

A shorter regimen of three cycles of adjuvant chemotherapy was noninferior to a standard six-cycle regimen among patients with pathologically high-risk retinoblastoma, a Chinese randomized trial ...

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma? The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A ...

Dr. Rachel Freedman and Dr. Sharon Giordano share the latest rapid guideline update from ASCO on the adjuvant use of the CDK4/6 inhibitors abemaciclib and ribociclib in patients with stage II and III ...

Preventive chemotherapy, or adjuvant chemotherapy, is administered after your primary cancer treatment. It’s used to destroy remaining cancer cells in your body that might be undetectable. Preventive ...

The odds of cancer returning, known as risk of recurrence, depends on several factors, including tumor type, stage, and size; ...

New NSCLC guideline updates outline expanded perioperative immunotherapy, adjuvant targeted therapy, and consolidation ...